Stevanato Group S.p.A. (STVN)
NYSE: STVN · IEX Real-Time Price · USD
20.71
-0.20 (-0.96%)
May 17, 2024, 4:00 PM EDT - Market closed

Stevanato Group Revenue

Stevanato Group had revenue of $1.18B in the twelve months ending March 31, 2024, with 7.31% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $256.52M, a -0.84% decrease year-over-year. In the year 2023, Stevanato Group had annual revenue of $1.21B with 15.24% growth.

Revenue (ttm)
$1.18B
Revenue Growth
+7.31%
P/S Ratio
4.81
Revenue / Employee
$209,010
Employees
5,634
Market Cap
5.67B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.21B159.48M15.24%
Dec 31, 20221.05B87.47M9.12%
Dec 31, 2021959.00M151.64M18.78%
Dec 31, 2020807.36M204.51M33.92%
Dec 31, 2019602.85M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organon & Co. 6.35B
DENTSPLY SIRONA 3.94B
Acadia Healthcare Company 2.99B
Exelixis 1.85B
Lantheus Holdings 1.37B
Halozyme Therapeutics 862.99M
Glaukos 326.43M
BridgeBio Pharma 218.60M
Revenue Rankings